{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:58:13Z","timestamp":1794002293433,"version":"4.8.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["RCBS20231211090734059"],"award-info":[{"award-number":["RCBS20231211090734059"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["T2541007"],"award-info":[{"award-number":["T2541007"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82504503"],"award-info":[{"award-number":["82504503"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574049"],"award-info":[{"award-number":["82574049"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82422066"],"award-info":[{"award-number":["82422066"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.amjmed.2026.04.031","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T22:55:42Z","timestamp":1778108142000},"page":"1348-1356.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Circulating Apolipoprotein E concentration and incident cardiovascular diseases: Evidence from an electronic health record-based cohort"],"prefix":"10.1016","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1922-7152","authenticated-orcid":false,"given":"Xia","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangshui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1026-1505","authenticated-orcid":false,"given":"Yinze","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunbao","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3075-3359","authenticated-orcid":false,"given":"Shiyuan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2088-0722","authenticated-orcid":false,"given":"Fengchao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongfeng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.amjmed.2026.04.031_bib0001","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306249","article-title":"Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology","volume":"118","author":"Nordestgaard","year":"2016","journal-title":"Circ Res."},{"issue":"11","key":"10.1016\/j.amjmed.2026.04.031_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113479","article-title":"Apoprotein E and reverse cholesterol transport","volume":"19","author":"Getz","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.amjmed.2026.04.031_bib0003","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","article-title":"Apolipoprotein E: far more than a lipid transport protein","volume":"1","author":"Mahley","year":"2000","journal-title":"Annu Rev Genom Hum Genet"},{"issue":"1","key":"10.1016\/j.amjmed.2026.04.031_bib0004","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/clinchem\/hvaa252","article-title":"Residual cardiovascular risk at low LDL: Remnants, Lipoprotein(a), and Inflammation","volume":"67","author":"Hoogeveen","year":"2021","journal-title":"Clin Chem"},{"issue":"47","key":"10.1016\/j.amjmed.2026.04.031_bib0005","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.amjmed.2026.04.031_bib0006","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/01.ATV.0000201282.64751.47","article-title":"Apolipoprotein E recycling: implications for dyslipidemia and atherosclerosis","volume":"26","author":"Heeren","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"10.1016\/j.amjmed.2026.04.031_bib0007","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1001\/jama.298.11.1300","article-title":"Association of apolipoprotein E genotypes with lipid levels and coronary risk","volume":"298","author":"Bennet","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2026.04.031_bib0008","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.atherosclerosis.2016.10.037","article-title":"Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: a review","volume":"255","author":"Rasmussen","year":"2016","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.amjmed.2026.04.031_bib0009","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12872-022-02566-0","article-title":"Meta-analysis of the association between apolipoprotein E polymorphism and risks of myocardial infarction","volume":"22","author":"Shao","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"issue":"33","key":"10.1016\/j.amjmed.2026.04.031_bib0010","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1093\/eurheartj\/ehz402","article-title":"Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105\u2009949 individuals from a white general population cohort","volume":"40","author":"Rasmussen","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjmed.2026.04.031_bib0011","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.atherosclerosis.2015.12.038","article-title":"Plasma levels of apolipoprotein E and risk of ischemic heart disease in the general population","volume":"246","author":"Rasmussen","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjmed.2026.04.031_bib0012","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1196\/annals.1395.012","article-title":"Plasma levels of apolipoprotein E and risk of stroke in old age","volume":"1100","author":"van Vliet","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1016\/j.amjmed.2026.04.031_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030176","article-title":"ApoE plasma levels and risk of cardiovascular mortality in old age","volume":"3","author":"Mooijaart","year":"2006","journal-title":"PLoS Med"},{"issue":"10","key":"10.1016\/j.amjmed.2026.04.031_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002146","article-title":"Circulating apolipoprotein E concentration and cardiovascular disease risk: meta-analysis of results from three studies","volume":"13","author":"Sofat","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.amjmed.2026.04.031_bib0015","article-title":"Time-dependent cardiovascular risks following pneumonia in inpatient and outpatient settings: a register-based cohort study","volume":"22","author":"Li","year":"2024","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"issue":"1","key":"10.1016\/j.amjmed.2026.04.031_bib0016","doi-asserted-by":"crossref","first-page":"81","DOI":"10.26599\/1671-5411.2024.01.005","article-title":"Multimorbidity and mortality among older patients with coronary heart disease in Shenzhen, China","volume":"21","author":"Li","year":"2024","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/j.amjmed.2026.04.031_bib0017","article-title":"Chinese guideline for lipid management","volume":"14","author":"Li","year":"2023","journal-title":"Front Pharmacol"},{"issue":"7","key":"10.1016\/j.amjmed.2026.04.031_bib0018","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.metabol.2011.11.010","article-title":"Apolipoprotein E predicts incident cardiovascular disease risk in women but not in men with concurrently high levels of high-density lipoprotein cholesterol and C-reactive protein","volume":"61","author":"Corsetti","year":"2012","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.amjmed.2026.04.031_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039110","article-title":"Apolipoprotein A-II influences apolipoprotein E-linked cardiovascular disease risk in women with high levels of HDL cholesterol and C-reactive protein","volume":"7","author":"Corsetti","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.amjmed.2026.04.031_bib0020","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1023\/B:BIRY.0000040195.34986.93","article-title":"Apolipoprotein E structure and substrate and receptor-binding activities of triglyceride-rich human plasma lipoproteins in normo- and hypertriglyceridemia","volume":"69","author":"Dergunov","year":"2004","journal-title":"Biochemistry (Mosc)"},{"issue":"Pt A","key":"10.1016\/j.amjmed.2026.04.031_bib0021","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2014.08.025","article-title":"Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer\u2019s diseases","volume":"72","author":"Huang","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.amjmed.2026.04.031_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.804214","article-title":"Small, dense low-density lipoprotein-cholesterol and atherosclerosis: relationship and therapeutic strategies","volume":"8","author":"Jin","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"10.1016\/j.amjmed.2026.04.031_bib0023","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","article-title":"Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management","volume":"32","author":"Chapman","year":"2011","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.amjmed.2026.04.031_bib0024","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s12012-024-09846-5","article-title":"Genetically predicted apolipoprotein E levels with the risk of panvascular diseases: a mendelian randomization study","volume":"24","author":"Shi","year":"2024","journal-title":"Cardiovasc Toxicol"},{"issue":"7","key":"10.1016\/j.amjmed.2026.04.031_bib0025","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1172\/JCI0216391","article-title":"Regulation and mechanisms of macrophage cholesterol efflux","volume":"110","author":"Tall","year":"2002","journal-title":"J Clin Invest"},{"issue":"17","key":"10.1016\/j.amjmed.2026.04.031_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179892","article-title":"Apolipoprotein E in cardiometabolic and neurological health and diseases","volume":"23","author":"Alagarsamy","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.amjmed.2026.04.031_bib0027","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cmet.2012.04.006","article-title":"Lipid metabolism and toxicity in the heart","volume":"15","author":"Goldberg","year":"2012","journal-title":"Cell Metab"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934326003761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934326003761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T21:10:23Z","timestamp":1787778623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934326003761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0002934326003761"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2026.04.031","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating Apolipoprotein E concentration and incident cardiovascular diseases: Evidence from an electronic health record-based cohort","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2026.04.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}